Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$113,706
+$2,210 QoQ
Shares Held
900
+12.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,983
of 2,266 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MRP Capital Investments, LLC holds $6,725,014 across 7 Drug Manufacturers - General names. GILD ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,932 | $3,516,728 | |
| 2 | JNJ |
Johnson & Johnson
|
6,201 | $1,574,867 | |
| 3 | PFE |
Pfizer Inc
|
47,847 | $1,152,155 | |
| 4 | AMGN |
Amgen Inc
|
650 | $235,378 | |
| 5 | ABBV |
AbbVie Inc.
|
512 | $128,839 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
900 | $113,706 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
58 | $3,341 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,706 | 900 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $111,496 | 800 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $98,192 | 800 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $11,087 | 100 | Shares | Sole | 2025-08-19 | |
| 2024-12-31 | $9,237 | 100 | Shares | Sole | 2025-02-11 | |
| 2023-06-30 | $61,656 | 800 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $803,647 | 9,686 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||